BioSpace News Archive

Opioid analgesics increase the risk of pneumonia among persons with Alzheimer’s disease

Opioid analgesics were associated with a 30% increase in the risk of pneumonia in persons with Alzheimer’s disease, a recent study from the University of Eastern Finland shows.

June 4, 2019
·
2 min read
Biotech Beach

Epigenomics AG to Participate in Raymond James Life Sciences and MedTech Conference in June

Epigenomics AG announced that company management will be presenting at the Raymond James Life Sciences and MedTech Conference in New York on Tuesday, June 18, 2019, at 1:50 pm / 7:50 pm and invites investors to participate by webcast.

June 4, 2019
·
1 min read
Drug Development

Minoryx Therapeutics announces first patient dosed in the FRAMES phase 2 trial in Friedreich’s Ataxia

Minoryx Therapeutics announces that the first patient has been dosed with its lead candidate, leriglitazone, in the phase 2 FRAMES clinical trial in Friedreich’s Ataxia.

June 4, 2019
·
4 min read
Business

Genedata Expressionist® 13.0 Streamlines In-depth Characterization and Automates Quality Monitoring of Biopharmaceuticals

Latest release of enterprise software solution that enhances efficiency of biopharmaceutical development with special focus on supporting Multi-Attribute Methods (MAM) showcased at 2019 ASMS

June 4, 2019
·
4 min read
Deals

Yukin Therapeutics raises €3.3 million to develop new cancer treatments

Yukin Therapeutics, a French company specializing in the development of new molecules for cancer treatment, has completed a €3.3 million financing round for the development and optimization of its proprietary therapeutic molecules.

June 4, 2019
·
4 min read
Biotech Bay

Bioz Launches the Next-Generation of Its Industry-Leading AI Search Engine for Life Science Experimentation

New AI Platform Accelerates Scientific Research and Drug Discovery, includes over 300 Million Product Listings from 50,000 Vendors

June 4, 2019
·
7 min read
Drug Development

Lymphoma trial finds combination targeted therapy effective prior to chemotherapy

MD Anderson Phase II study suggests patients with lymphoma subtype may be able to avoid chemotherapy in the future

June 4, 2019
·
2 min read
Drug Development

GENFIT Launches a Phase 2 Trial Evaluating Elafibranor on Hepatic Lipid Composition for NAFL

GENFIT announced the launch of a P2 clinical trial evaluating elafibranor’s activity on liver fat quantity and – most importantly – fat composition in nonalcoholic fatty liver disease (NAFLD) patients.

June 4, 2019
·
8 min read
From Fly-Over to “Fly-To” Country: BioSTL Attracts International Health Care Innovators to St. Louis

The GlobalSTL Health Innovation Summit brings new international technologies to local health care systems to create competitive advantage and economic impact in St. Louis

June 4, 2019
·
7 min read